233 related articles for article (PubMed ID: 33052268)
1. Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab.
Ahmed M; Yassin MA; Abdelmahmuod E
Cureus; 2020 Sep; 12(9):e10305. PubMed ID: 33052268
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag Dose Adjustment During Infection-Induced Thrombocytosis in a Patient With Chronic Idiopathic Thrombocytopenic Purpura.
Ahmed M; Abdelmahmuod E; Ali EA; Yassin MA
Cureus; 2021 Mar; 13(3):e14166. PubMed ID: 33936878
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
Chouhan JD; Herrington JD
Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
[TBL] [Abstract][Full Text] [Related]
4. Treatment-Free Remission in Chronic Idiopathic Thrombocytopenic Purpura.
Ahmed M; Yassin MA
Cureus; 2020 Jun; 12(6):e8705. PubMed ID: 32699701
[TBL] [Abstract][Full Text] [Related]
5. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
Osman ME
Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
[TBL] [Abstract][Full Text] [Related]
6. Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis.
Puavilai T; Thadanipon K; Rattanasiri S; Ingsathit A; McEvoy M; Attia J; Thakkinstian A
Br J Haematol; 2020 Feb; 188(3):450-459. PubMed ID: 31423574
[TBL] [Abstract][Full Text] [Related]
7. Refractory severe idiopathic thrombocytopenia and treatment challenges.
Shahnazi A; Johnston B; Hargrove M; Patolia H; Junko G
Ann Med Surg (Lond); 2023 Apr; 85(4):973-975. PubMed ID: 37113966
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
Kikuchi K; Miyakawa Y; Ikeda S; Sato Y; Takebayashi T
BMC Health Serv Res; 2015 Jan; 15():2. PubMed ID: 25609557
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M
J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.
Kim YK; Lee SS; Jeong SH; Ahn JS; Yang DH; Lee JJ; Kim HJ
Blood Res; 2015 Mar; 50(1):19-25. PubMed ID: 25830126
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy.
Ahmed MA; Yassin MA
Case Rep Oncol; 2020; 13(2):655-658. PubMed ID: 32774251
[TBL] [Abstract][Full Text] [Related]
13. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
15. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
Mori M; Kato M; Koh K; Hanada R
Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
[TBL] [Abstract][Full Text] [Related]
16. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
[TBL] [Abstract][Full Text] [Related]
17. Review article: second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults.
Lam MS
J Oncol Pharm Pract; 2010 Jun; 16(2):89-103. PubMed ID: 19525300
[TBL] [Abstract][Full Text] [Related]
18. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
Bussel JB; Cheng G; Saleh MN; Psaila B; Kovaleva L; Meddeb B; Kloczko J; Hassani H; Mayer B; Stone NL; Arning M; Provan D; Jenkins JM
N Engl J Med; 2007 Nov; 357(22):2237-47. PubMed ID: 18046028
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of immune thrombocytopenia.
Červinek L
Vnitr Lek; 2018; 64(5):526-529. PubMed ID: 30193522
[TBL] [Abstract][Full Text] [Related]
20. Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review.
Shibata S; Misugi T; Nakane T; Hino M; Tachibana D
Cureus; 2022 Feb; 14(2):e22505. PubMed ID: 35371812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
